Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

Morling JR, Fallowfield JA, Guha IN, Nee LD, Glancy S, Williamson RM, Robertson CM, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study investigators.

J Hepatol. 2014 Feb;60(2):384-91. Epub 2013 Oct 26.

PMID:
24512822
[PubMed - indexed for MEDLINE]
2.

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.

Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).

BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2.

PMID:
22221544
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.

Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ; Nash Clinical Research Network.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12. doi: 10.1016/j.cgh.2009.05.033. Epub 2009 Jun 10.

PMID:
19523535
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.

Casey SP, Kemp WW, McLean CA, Topliss DJ, Adams LA, Roberts SK.

Scand J Gastroenterol. 2012 Jul;47(7):836-41. doi: 10.3109/00365521.2012.677955. Epub 2012 Apr 23.

PMID:
22519948
[PubMed - indexed for MEDLINE]
5.

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.

Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.

PMID:
20801772
[PubMed - indexed for MEDLINE]
6.

A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.

Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Kim do Y.

Liver Int. 2010 Aug;30(7):1073-81. doi: 10.1111/j.1478-3231.2010.02269.x. Epub 2010 May 21.

PMID:
20492510
[PubMed - indexed for MEDLINE]
7.

APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

Kruger FC, Daniels CR, Kidd M, Swart G, Brundyn K, van Rensburg C, Kotze M.

S Afr Med J. 2011 Jun 27;101(7):477-80.

PMID:
21920102
[PubMed - indexed for MEDLINE]
8.

Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH.

World J Gastroenterol. 2012 Jun 21;18(23):2988-94. doi: 10.3748/wjg.v18.i23.2988.

PMID:
22736923
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1904-8.

PMID:
17914968
[PubMed - indexed for MEDLINE]
10.

Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver.

Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Løberg EM, Haukeland JW.

Scand J Gastroenterol. 2013 Jan;48(1):93-100. doi: 10.3109/00365521.2012.746389. Epub 2012 Dec 3.

PMID:
23205894
[PubMed - indexed for MEDLINE]
11.

Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.

Deghady A, Abdou A, El-Neanaey WA, Diab I.

Genet Test Mol Biomarkers. 2012 Jun;16(6):531-5. doi: 10.1089/gtmb.2011.0098. Epub 2012 Feb 21.

PMID:
22352690
[PubMed - indexed for MEDLINE]
12.

Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients.

Lee VS, Miller FH, Omary RA, Wang Y, Ganger DR, Wang E, Rao S, Levitsky J.

Transplantation. 2011 Sep 15;92(5):581-6. doi: 10.1097/TP.0b013e31822805fa.

PMID:
21822174
[PubMed - indexed for MEDLINE]
13.

Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.

Pérez-Gutiérrez OZ, Hernández-Rocha C, Candia-Balboa RA, Arrese MA, Benítez C, Brizuela-Alcántara DC, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC.

Ann Hepatol. 2013 May-Jun;12(3):416-24.

PMID:
23619258
[PubMed - indexed for MEDLINE]
14.

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD).

Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M.

BMC Gastroenterol. 2010 Jun 28;10:67. doi: 10.1186/1471-230X-10-67.

PMID:
20584330
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.

Lin CS, Chang CS, Yang SS, Yeh HZ, Lin CW.

Intern Med. 2008;47(7):569-75. Epub 2008 Apr 1.

PMID:
18379139
[PubMed - indexed for MEDLINE]
Free Article
16.

External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients.

Kim BK, Han KH, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Kim do Y.

Dig Dis Sci. 2010 Sep;55(9):2636-43. doi: 10.1007/s10620-009-1070-3. Epub 2009 Dec 4.

PMID:
19960253
[PubMed - indexed for MEDLINE]
17.

Prevalence and markers of advanced liver disease in type 2 diabetes.

Williamson RM, Price JF, Hayes PC, Glancy S, Frier BM, Johnston GI, Reynolds RM, Strachan MW; Edinburgh Type 2 Diabetes Study Investigators.

QJM. 2012 May;105(5):425-32. doi: 10.1093/qjmed/hcr233. Epub 2011 Dec 7.

PMID:
22156706
[PubMed - indexed for MEDLINE]
Free Article
18.

Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.

Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP.

J Hepatol. 2007 May;46(5):775-82. Epub 2007 Jan 26.

PMID:
17321634
[PubMed - indexed for MEDLINE]
19.

Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.

Xun YH, Fan JG, Zang GQ, Liu H, Jiang YM, Xiang J, Huang Q, Shi JP.

J Dig Dis. 2012 Nov;13(11):588-95. doi: 10.1111/j.1751-2980.2012.00631.x.

PMID:
23107446
[PubMed - indexed for MEDLINE]
20.

[Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].

Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.

Korean J Hepatol. 2009 Dec;15(4):454-63. doi: 10.3350/kjhep.2009.15.4.454. Korean.

PMID:
20037264
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk